Академический Документы
Профессиональный Документы
Культура Документы
Lisham Ashrafioun
Melatonin
vivo.colostate.edu
Melatonin
Receptors (ML1A)
CNS locations
SCN (biological clock) Anterior pituitary (seasonal breeding) Retina - circadian and reproductive responses Cardiovascular system - caudal artery that potentiates NEinduced contraction Reproductive system ovaries Immune system T cells Kidneys Na retention GI Tract relaxes smooth muscles (melatonin-5-HT feedback)
PNS locations
Serotonin
5-Hydroxytryptamine (5-HT)
Synthesis
Tryptophan
Tryptophan Hydroxylase
5-Hydroxytrophan (5-HTP)
5-Hydroxytryptamine (5-HT)
Metabolism
5-HT
Monoamine Oxidase
5-HIAA
Distribution(PNS)
Responsible for smooth muscle contractions Release stimulated by food intake Inhibits release of gastric acid Softens stool
Bonchioconstriction
Uterine contractions
Distribution: rodent
5HT Receptors
receptor 5HT1 5HT2 5HT3 5HT4 5ht5 5ht6 5HT7
subtype
5HT3A, 5HT3B
5ht1A, 5ht1B
ion channel
cAMP
cAMP? cAMP
cAMP
4 Families of Receptors
Channel linked (Ionotropic) G-protein coupled (Metabotropic)
Ionotropic receptors
Gq Activates phospholipase C
Go - Inhibits Ca channels G12/13 Diverse ion transporter interactions
http://www.endocrinesurgeon.co.uk
Second MessengerPhospholipase C
http://www.endocrinesurgeon.co.uk
5HT1A receptor
CNSforum.com
Migraine Hypertension Pulmonary hypertension Eating disorders Vomiting Irritable bowel syndrome
Serotenergic Drugs
5HT1A Buspirone, ipsapirone treat anxiety, depression (partial agonist) 5HT1D Sumatriptan, treat migraine (partial agonist)
5HT2A/2C methysergide, trazodone, risperidone, ketanserin treat migraine, depression, schizophrenia (antagonist)
Drugs continued
5HT3 Ondansetron treat chemotherapyinduced emesis (antagonist) 5HT4 Cisapride treat GI disorders (agonist) 5HT transporter SSRIs (Fluoxetine, sertraline) treat depression, OCD, panic disorder, social phobia, post traumatic stress disorder (inhibitor)
Antidepressants
Decreased amounts and impaired function of 5-HT associated with aggression, depression and other forms of antisocial behavior Antidepressants attempt to increase 5-HT levels
Serotonin Syndrome
Toxic, potentially fatal effects require a combination of serotonergic agents, such as an SSRI with an MAOI. Symptoms: euphoria, drowsiness, sustained rapid eye movement, overreaction of reflexes, rapid muscle contraction,abnormal movements of the foot, drunk, dizzy feeling,high body temperature, shivering , diarrhea ,loss of consciousness, death
Treatment
suspected agents should be discontinued OTC drugs containing ingredients known to increase serotonin levels, such as dextromethorphan, pseudoephedrine or phenylpropanolamine, also should be discontinued. Benzodiazepines for mild to moderate cases
Cyproheptadine, Methysergide, and Propranolol for severe cases
Oh man I just saw God and he was playing a mandolin and he told me to watch Fear and Loathing in Las Vegas while listening to The Doors self-titled album and dude they totally go together LSD
Non-selective 5HT agonist/partial agonist Ergot derivative Mimics 5HT at 5HT1A autoreceptors on raphe cell bodies, slows firing rate of serotonergic neurons Current theories focus on glutamate release in thalamocortical terminals, causing dissociation between sensory relay and cortical output
Animal model thought to reflect subjective effects Mediated by activation of 5HT2A receptors Acts as partial or full agonist at 5HT2A and 5HT2C receptors Phenethylamine derivatives (psilocybin) are selective 5HT2A/2C agonists
Human Studies
Psilocybin and PET imaging studiespattern resembles brain activation in schizophrenic patients Action of psilocybin is blocked by pretreatment with 5HT2A/2C antagonists
MDMA causes an increased release of 5HT and blocks reuptake High affinity for SERT Effects fine axons Responsible for temperature increases
Receptor Overview
5HT2 subtypes